a month ago
HRMY
AnalystsCharles DuncanCharles Duncan's Stock Forecasts
AnalystsCharles Duncan
Analyst Ranking
Top 4%
#179 out of 4755 analysts
Average Return
+14.37%
Win Rate
50%104 out of 207
Risk vs Reward
Poor
Good
Charles Duncan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Novavax IncNVAX | +2,273.26% | $9.50 | $225.46 | 2020-03-16 - 2021-03-17 | Strong Buy |
Cassava Sciences IncSAVA | +390.45% | $9.32 | $45.71 | 2020-10-22 - 2021-10-22 | Strong Buy |
Biohaven LtdBHVN | +282.44% | $13.67 | $52.28 | 2023-04-03 - 2024-04-03 | Strong Buy |
Crinetics Pharmaceuticals IncCRNX | +210.47% | $17.38 | $53.96 | 2023-08-21 - 2024-08-21 | Strong Buy |
Solid Biosciences IncSLDB | +184.78% | $2.76 | $7.86 | 2023-09-21 - 2024-09-20 | Strong Buy |
Charles Duncan Analyst Color
Get additional color on Charles Duncan's coverage of popular stocks
3 months ago
ITCI
4 months ago
ITCI
a year ago
CYTK
a year ago
CYBN
a year ago
CPRX
a year ago
RETA
2 years ago
PRTA
2 years ago
ITCI
2 years ago
HRMY
2 years ago
BHVN
2 years ago
ITCI
2 years ago
RETA
2 years ago
CLNN
2 years ago
RETA
2 years ago
PRTA
2 years ago
FENC
2 years ago
AXSM
2 years ago
NVAX
Charles Duncan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Marinus Pharmaceuticals IncMRNS | 9 | Strong Buy | $4.00 | +1,328.57% | Reiterates | 22 days ago |
Harmony Biosciences Holdings IncHRMY | 8 | Strong Buy | $58.00 | +73.19% | Maintains | a month ago |
Alkermes PLCALKS | 5 | Strong Buy | $43.00 | +37.86% | Maintains | a month ago |
Intra Cellular Therapies IncITCI | 17 | Strong Buy | $130.00 | +54.60% | Reiterates | 3 months ago |
Axsome Therapeutics IncAXSM | 18 | Strong Buy | $107.00 | +8.80% | Reiterates | 3 months ago |
Neurocrine Biosciences IncNBIX | 8 | Strong Buy | $155.00 | +22.61% | Reiterates | 3 months ago |
Jazz Pharmaceuticals PLCJAZZ | 5 | Strong Buy | $140.00 | +13.69% | Reiterates | 3 months ago |
Denali Therapeutics IncDNLI | 6 | Strong Buy | $35.00 | +50.09% | Reiterates | 3 months ago |
Acadia Pharmaceuticals IncACAD | 15 | Strong Buy | $28.00 | +67.56% | Maintains | 4 months ago |
Vanda Pharmaceuticals IncVNDA | 3 | Strong Buy | $13.00 | +171.97% | Maintains | 4 months ago |
Catalyst Pharmaceuticals IncCPRX | 7 | Strong Buy | $34.00 | +56.68% | Reiterates | 8 months ago |
Karuna Therapeutics IncKRTX | 4 | Hold | $330.00 | +0.05% | Reiterates | 10 months ago |
Prothena Corp Public Ltd CoPRTA | 11 | Strong Buy | $87.00 | +524.55% | Maintains | a year ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $45.00 | +0.09% | Downgrades | a year ago |
Crinetics Pharmaceuticals IncCRNX | 3 | Strong Buy | $50.00 | N/A | Assumes | a year ago |
Cytokinetics IncCYTK | 5 | Strong Buy | $65.00 | N/A | Maintains | a year ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | a year ago |
Vaxart IncVXRT | 4 | Strong Buy | $4.00 | N/A | Reiterates | a year ago |
Cybin IncCYBN | 4 | Strong Buy | $114.00 | N/A | Reiterates | a year ago |
Lucid Diagnostics IncLUCD | 4 | Strong Buy | $4.00 | N/A | Reiterates | a year ago |
Xenon Pharmaceuticals IncXENE | 3 | Strong Buy | $58.00 | N/A | Reiterates | a year ago |
Seelos Therapeutics IncSEELQ | 6 | Strong Buy | $7,680.00 | N/A | Reiterates | a year ago |
Mind Medicine IncMNMD | 2 | Strong Buy | $7.00 | N/A | Reiterates | a year ago |
Lumos Pharma IncLUMO | 4 | Strong Buy | $10.00 | N/A | Reiterates | a year ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $20.00 | N/A | Reiterates | a year ago |
Biovie IncBIVI | 4 | Strong Buy | $110.00 | N/A | Reiterates | a year ago |
Clene IncCLNN | 5 | Strong Buy | $80.00 | N/A | Reiterates | a year ago |
Reata Pharmaceuticals IncRETA | 7 | Hold | $172.00 | N/A | Reiterates | a year ago |
Cardiol Therapeutics IncCRDL | 2 | Strong Buy | $3.00 | N/A | Reiterates | a year ago |
Stoke Therapeutics IncSTOK | 4 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Biohaven LtdBHVN | 2 | Strong Buy | $31.00 | N/A | Reiterates | a year ago |
Anavex Life Sciences CorpAVXL | 2 | Hold | $11.00 | N/A | Downgrades | 2 years ago |
Fennec Pharmaceuticals IncFENC | 2 | Strong Buy | $12.00 | N/A | Upgrades | 2 years ago |
Cognition Therapeutics IncCGTX | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Novavax IncNVAX | 6 | Strong Buy | $168.00 | N/A | Maintains | 2 years ago |
Aptinyx IncAPTX | 1 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
Oramed Pharmaceuticals IncORMP | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Vtv Therapeutics IncVTVT | 3 | Strong Buy | $200.00 | N/A | Initiates Coverage On | 3 years ago |
Bionomics LimitedBNOX | 1 | Strong Buy | $52.00 | N/A | Initiates Coverage On | 3 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 4 | Strong Buy | $165.00 | N/A | Maintains | 3 years ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Ovid Therapeutics IncOVID | 1 | Hold | $4.00 | N/A | Downgrades | 4 years ago |
Cassava Sciences IncSAVA | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Inovio Pharmaceuticals IncINO | 4 | Hold | $144.00 | N/A | Downgrades | 4 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 4 years ago |
Geron CorpGERN | 1 | Strong Buy | $4.00 | N/A | Maintains | 5 years ago |
Halozyme Therapeutics IncHALO | 2 | Strong Buy | $39.00 | N/A | Reiterates | 5 years ago |
Cara Therapeutics IncCARA | 1 | Strong Buy | $34.00 | N/A | Reiterates | 5 years ago |
Aimmune Therapeutics IncAIMT | 2 | Strong Buy | $32.00 | N/A | Maintains | 5 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Hold | $7.00 | N/A | Reiterates | 5 years ago |
Corcept Therapeutics IncCORT | 3 | Hold | $14.00 | N/A | Downgrades | 6 years ago |
Acorda Therapeutics IncACORQ | 1 | Hold | $3,840.00 | N/A | Initiates Coverage On | 6 years ago |
Sangamo Therapeutics IncSGMO | 1 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Altimmune IncALT | 1 | Strong Buy | $180.00 | N/A | Initiates Coverage On | 7 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Pdl Biopharma IncPDLI | 1 | Strong Buy | $4.00 | N/A | Reinstates | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.